MC
SYNH

Martin & Co’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Martin & Co’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-118,550
Closed -$5M – 112
2023
Q2 		$5M Buy
118,550
+20,653
+21% +$835K 1.26% 26
2023
Q1 		$3.49M Buy
97,897
+34,746
+55% +$1.26M 0.9% 36
2022
Q4 		$2.32M Sell
63,151
-3,939
-6% -$156K 0.61% 64
2022
Q3 		$3.16M Buy
+67,090
New +$4.33M 0.94% 36

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $88.9B AUM 38.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $46.7B AUM 50.59% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Martin & Co's SYNH Position: Q3 2023 in Review

Martin & Co sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 118,550 shares — an estimated $5M sold.

Martin & Co first reported a position in SYNH in Q3 2022 and held it in 4 quarters. The position peaked at $5M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Martin & Co reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Martin & Co sold 118,550 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $5M.
  • Martin & Co first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2022 and held it in 4 quarters.
  • Martin & Co's Syneos Health, Inc. Class A Common Stock position peaked at $5M in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Martin & Co's 13F filing for Q3 2023, filed 2 Nov 2023.